Novugen Pharma Uzbekistan is a wholly owned subsidiary of Novugen Pharma. This facility was acquired by the group in 2019 and revamped according to the latest cGMP requirements to facilitate entry into the Commonwealth Independent States (CIS) and Eurasian markets. The acquisition strategically positioned Novugen in the growing regions, giving us stronger access in the markets. Our presence in CIS is aligned with the company’s vision to expand our reach globally.
Novugen Pharma’s FDF manufacturing facility in Uzbekistan was acquired in 2019. Thenceforth, we are fully operational and launched over 25 products which were developed in our global R&D centre in Malaysia. Leveraging on this acquisition, we can cater to major therapeutic areas and expand our existing global portfolio.
Therapeutic Segment: |
Anti-lipidemic |
Generic Name: |
Rosuvastatin Calcium |
Indication: |
Hyperlipidemia and mixed dyslipidemia,
|
Strength(s): |
5mg 10mg 20mg |
Dosage Form: |
Tablets |
Therapeutic Segment: |
Antibiotic |
Generic Name: |
Moxifloxacin Hydrochloride |
Indication: |
Community acquired pneumonia
|
Strength(s): |
400mg |
Dosage Form: |
Tablets |
Therapeutic Segment: |
Antibiotic |
Generic Name: |
Azithromycin |
Indication: |
Mild to moderate infections:
|
Strength(s): |
250mg
|
Dosage Form: |
Tablets |
Therapeutic Segment: |
Antibiotic |
Generic Name: |
Ciprofloxacin |
Indication: |
Skin and skin structure infections
|
Strength(s): |
250mg
|
Dosage Form: |
Capsules |
Therapeutic Segment: |
Anti-inflammatory |
Generic Name: |
Diclofenac Sodium + Paracetamol |
Indication: |
Mild to moderate musculoskeletal pain
|
Strength(s): |
50mg + 500mg |
Dosage Form: |
Tablets |
Therapeutic Segment: |
Anti-histamine |
Generic Name: |
Loratidine 10 mg |
Indication: |
Seasonal allergic rhinitis
|
Strength(s): |
10mg |
Dosage Form: |
Tablets |